BCPSQC Quality Awards: Nominate People and Projects That Made Health Care Better!May15

Did your project improve how health care is delivered? Orr do you know somebody whose contributions to quality of care deserve recognition?

Nominations are now being accepted for the BC Patient Safety & Quality Council’s 2018 Quality Awards.

Categories celebrate projects within the four areas of care, as well as four inspiring people.

The deadline to submit nominations is June 30, 2017. Judging criteria and nomination forms are available at www.bcpsqc.ca/quality-awards.

Categories

  • Staying Healthy – A project that better prevented injury, illness or disability.
  • Getting Better – A project that improved care for acute illness or injury.
  • Living with Illness – A project that improved care and support for chronic illness and/or injury.
  • Coping with End of Life – A project that improved planning, care or support for life-limiting illness and bereavement.
  • Leadership in Quality – An individual who demonstrates outstanding leadership in improving the quality of care.
  • Everyday Champion Award – Someone who shows a passion and commitment for improving quality of care, even though they may not work in a leadership position or a role that specifies participation in improvement actThe judging panel will select the candidates who best exemplify the award’s criteria and the winner will be selected through online voting open to everyone in BC.
  • Quality Culture Trailblazer – Someone who created an environment where passionate staff are empowered and encouraged to innovate, and where teamwork and open communication are the norm.
  • Leadership in Advancing the Patient Voice – A patient, caregiver or family member who made an outstanding contribution to advancing the patient voice in BC’s health care system. The nominee will have assumed a leadership role and will have contributed in any number of meaningful ways, such as inspiring patients and health care organizations to collaborate in pursuit of better health care.

Recognition

Winners will be awarded a $2,500 sponsorship to support and disseminate learning from their projects or to support ongoing learning and development, and will be recognized at an awards ceremony at Health Talks on February 21, 2018. Winners will also receive complimentary registration for the Quality Forum on February 22 & 23, 2018, and winners of the four project-based awards will be invited to present at the Forum.

You can help celebrate and spread great work that improved our health system – submit your nomination by June 30, 2017 at www.bcpsqc.ca/quality-awards! Contact awards@bcpsqc.ca or 604.668.8210 with questions.

You can also download a printable poster here.

 

MORE

CIPHI Conference: Call for AbstractsMay11

CIPHI

Do you have ideas to share about current and emerging environmental public health issues?  An innovative way to safeguard public health? Submit your abstract today and connect with environmental public health professionals from all across Canada!

Share your educational content on topics related to:

  • Air Quality
  • Built Environment
  • Communicable Disease & Infection Control
  • Drinking Water
  • Emergency Preparedness & Response
  • Food Safety
  • Indigenous Populations
  • Personal Services
  • Pest Management
  • Recreational Water

Download the abstract submission form (PDF). Deadline for abstract submission: June 9, 2017

About the Conference

November 5 – 8, 2017 | Richmond, BC, Canada

The Canadian Institute of Public Health Inspectors (CIPHI) – BC Branch and Vancouver Coastal Health Authority will jointly host the 83rd CIPHI Annual Education Conference on November 5 – 8, 2017 at the Sheraton Vancouver Airport Hotel in Richmond, BC, Canada. This education conference will focus on current and emerging environmental public health issues and explore innovative ways to safeguard public health.

Visit the CIPHI conference webpage for more information.

MORE

Three African countries chosen to test first malaria vaccineApr25

Three African countries have been chosen to test the world’s first malaria vaccine, the World Health Organization announced Monday. Ghana, Kenya and Malawi will begin piloting the injectable vaccine next year with hundreds of thousands of young children, who have been at highest risk of death.

The vaccine, which has partial effectiveness, has the potential to save tens of thousands of lives if used with existing measures, the WHO regional director for Africa, Dr. Matshidiso Moeti, said in a statement. The challenge is whether impoverished countries can deliver the required four doses of the vaccine for each child.

Malaria remains one of the world’s most stubborn health challenges, infecting more than 200 million people every year and killing about half a million, most of them children in Africa. Bed netting and insecticides are the chief protection.

Sub-Saharan Africa is hardest hit by the disease, with about 90 per cent of the world’s cases in 2015. Malaria spreads when a mosquito bites someone already infected, sucks up blood and parasites, and then bites another person.

A global effort to counter malaria has led to a 62 per cent cut in deaths between 2000 and 2015, WHO said. But the U.N. agency has said in the past that such estimates are based mostly on modeling and that data is so bad for 31 countries in Africa — including those believed to have the worst outbreaks — that it couldn’t tell if cases have been rising or falling in the last 15 years.

The vaccine will be tested on children five to 17 months old to see whether its protective effects shown so far in clinical trials can hold up under real-life conditions. At least 120,000 children in each of the three countries will receive the vaccine, which has taken decades of work and hundreds of millions of dollars to develop.

Kenya, Ghana and Malawi were chosen for the vaccine pilot because all have strong prevention and vaccination programs but continue to have high numbers of malaria cases, WHO said. The countries will deliver the vaccine through their existing vaccination programs.

WHO is hoping to wipe out malaria by 2040 despite increasing resistance problems to both drugs and insecticides used to kill mosquitoes.

“The slow progress in this field is astonishing, given that malaria has been around for millennia and has been a major force for human evolutionary selection, shaping the genetic profiles of African populations,” Kathryn Maitland, professor of tropical pediatric infectious diseases at Imperial College London, wrote in The New England Journal of Medicine in December. “Contrast this pace of change with our progress in the treatment of HIV, a disease a little more than three decades old.”

You can read the full article on CBC.ca.

MORE

Comparison of VRE infection rates in Ontario hospitalsApr18

This paper was published in the Canadian Medical Association Journal (CMAJ) on April 4, 2017 (vol.5 no.2 E273-E280)

Abstract

Background: Some Ontario hospitals have discontinued active screening and isolation programs for vancomycin-resistant Enterococcus (VRE). The aim of this study was to determine whether this practice change is associated with a change in the rate of rise of VRE-positive blood cultures.

Methods: All Ontario hospitals are mandated to report VRE bacteremia. Using this publicly reported data set, we included all validated results between January 2009 and June 2015. Beginning in June 2012, some hospitals discontinued active VRE screening and isolation programs (intervention). We used an interrupted time series Poisson regression to assess the slope change in the incidence rate of VRE-positive blood cultures (primary outcome) after versus before the intervention. Hospitals that continued to screen were the comparison group. Incidence rates were adjusted for hospital type and clustering within hospital site; slope changes are presented as incidence rate ratios (IRRs) with 95% confidence intervals (CIs).

Results: In hospitals that had ceased screening (n = 13), there was an increase in slope after screening and isolation were discontinued compared with before screening and isolation were discontinued (slope change IRR 1.25 [95% CI 1.01-1.54]). In hospitals that continued screening (n = 50), the slope was not significantly different after June 2012 compared with before June 2012 (slope change IRR 0.81 [95% CI 0.56-1.15]).

Interpretation: There was a significant increase in the rate of rise of VRE-positive blood cultures in hospitals that discontinued active VRE screening and isolation programs but not in hospitals that continued to screen and isolate. Hospitals aiming to minimize rising rates should consider maintaining active screening and isolation programs.

You can read the full paper on the CMAJ Open website.

MORE